These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 25985062

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Translation and linguistic validation of the Japanese version of the wearing-off questionnaires(WOQ-19 and WOQ-9)].
    Kondo T, Takahashi K.
    Brain Nerve; 2011 Nov; 63(11):1285-92. PubMed ID: 22068482
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Wearing off: A complex phenomenon often poorly recognized in Parkinson's disease. A study with the WOQ-19 questionnaire.
    Pistacchi M, Gioulis M, Sanson F, Marsala SZ.
    Neurol India; 2017 Nov; 65(6):1271-1279. PubMed ID: 29133700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study.
    Ouma S, Fukae J, Fujioka S, Yamamoto S, Hatano T, Yoritaka A, Okuma Y, Kashihara KI, Hattori N, Tsuboi Y.
    Intern Med; 2017 Nov; 56(15):1961-1966. PubMed ID: 28768964
    [Abstract] [Full Text] [Related]

  • 7. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease.
    Stacy M, Hauser R.
    J Neural Transm (Vienna); 2007 Feb; 114(2):211-7. PubMed ID: 16897594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease.
    Chen H, Fang J, Li F, Gao L, Feng T.
    Neurol Sci; 2015 Jul; 36(7):1217-23. PubMed ID: 25616444
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?
    Bareš M, Rektorová I, Jech R, Farníková K, Roth J, Růžička E, Kaňovský P, Rektor I, Pavlík T, Uhlířová L, Vydlák J.
    J Neural Transm (Vienna); 2012 Mar; 119(3):373-80. PubMed ID: 21769622
    [Abstract] [Full Text] [Related]

  • 12. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.
    Santens P, de Noordhout AM, Belgian EODWO Study Group.
    Acta Neurol Belg; 2006 Sep; 106(3):137-41. PubMed ID: 17091617
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of wearing-off manifestations (reduction of levodopa effect) in Parkinson's disease using specific questionnaire and comparison of the results with routine ambulatory evaluations.
    Melo LM, Chien HF, Barbosa ER.
    Arq Neuropsiquiatr; 2010 Aug; 68(4):506-10. PubMed ID: 20730301
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F.
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gender and non motor fluctuations in Parkinson's disease: A prospective study.
    Picillo M, Palladino R, Moccia M, Erro R, Amboni M, Vitale C, Barone P, Pellecchia MT.
    Parkinsonism Relat Disord; 2016 Jun; 27():89-92. PubMed ID: 27066847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.